TerminatedNCT01398774
Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a
Studying Albright hereditary osteodystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Hospital of Philadelphia
- Principal Investigator
- Michael A Levine, M.D.Children's Hospital of Philadelphia
- Enrollment
- 519 enrolled
- Eligibility
- 5-45 years · All sexes
- Timeline
- 2011 – 2017
Study locations (1)
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01398774 on ClinicalTrials.govOther trials for Albright hereditary osteodystrophy
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT04551170Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years OldVanderbilt University Medical Center
- ACTIVE NOT RECRUITINGPHASE2NCT03029429Theophylline Treatment for PseudohypoparathyroidismVanderbilt University Medical Center
- RECRUITINGNANCT00209235Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral AssessmentsConnecticut Children's Medical Center